CSPC Pharmaceutical Group Limited (HKG: 1093)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.640
-0.130 (-2.73%)
Sep 9, 2024, 1:21 PM HKT

CSPC Pharmaceutical Group Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
54,57486,02297,707100,93294,800115,871
Upgrade
Market Cap Growth
-9.27%-11.96%-3.19%6.47%-18.19%64.42%
Upgrade
Enterprise Value
45,11174,60084,55788,21287,594111,142
Upgrade
Last Close Price
4.667.117.717.777.158.59
Upgrade
PE Ratio
8.6713.0513.3513.4913.9624.71
Upgrade
PS Ratio
1.622.482.792.953.204.69
Upgrade
PB Ratio
1.472.232.733.063.465.31
Upgrade
P/FCF Ratio
-30.5615.9825.4814.8354.49
Upgrade
P/OCF Ratio
-18.6911.3317.7311.8427.37
Upgrade
EV/Sales Ratio
1.332.152.422.582.964.49
Upgrade
EV/EBITDA Ratio
5.108.539.8310.3111.9819.67
Upgrade
EV/EBIT Ratio
5.889.6511.0711.5013.4822.33
Upgrade
EV/FCF Ratio
-26.5013.8322.2713.7052.26
Upgrade
Debt / Equity Ratio
0.010.020.020.000.010.01
Upgrade
Debt / EBITDA Ratio
0.050.090.080.010.050.04
Upgrade
Debt / FCF Ratio
-0.280.110.030.060.10
Upgrade
Asset Turnover
0.690.710.810.860.880.89
Upgrade
Inventory Turnover
2.923.263.453.102.852.16
Upgrade
Quick Ratio
2.202.322.392.472.221.70
Upgrade
Current Ratio
2.542.632.672.812.532.20
Upgrade
Return on Equity (ROE)
17.34%18.22%21.32%22.78%24.54%21.30%
Upgrade
Return on Assets (ROA)
9.86%9.96%11.04%12.05%12.13%11.23%
Upgrade
Return on Capital (ROIC)
12.75%12.91%14.29%15.52%15.86%15.74%
Upgrade
Earnings Yield
11.54%7.52%7.05%6.82%6.46%3.59%
Upgrade
FCF Yield
3.27%6.26%3.92%6.74%1.84%
Upgrade
Dividend Yield
6.71%3.94%2.80%2.40%1.78%1.23%
Upgrade
Payout Ratio
0.00%46.42%34.42%30.16%29.61%25.99%
Upgrade
Buyback Yield / Dilution
0.51%0.38%0.30%0.01%0.00%0.24%
Upgrade
Total Shareholder Return
7.22%4.32%3.10%2.42%1.79%1.48%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.